Publication: 140 Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention
Open/View Files
Date
2014
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
JAIDS Journal of Acquired Immune Deficiency Syndromes
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Essex, M. 2014. “140 Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention.” Journal of Acquired Immune Deficiency Syndromes (1999) 65 (Suppl 2): 59. doi:10.1097/01.qai.0000446720.60423.1e. http://dx.doi.org/10.1097/01.qai.0000446720.60423.1e.
Research Data
Abstract
The epidemic of HIV-1C in southern Africa is characterized by a sustained prevalence that is substantially higher than for other epidemics of HIV/AIDS. Perhaps the best correlate of transmission is high viral load (HVL), which we target to prevent spread of HIV in a community randomization trial based on antiretroviral treatment (ART) as prevention (TasP). Designed for over 100,000 adults in 30 randomized villages in Botswana, this trial also utilizes other prevention interventions such as HIV testing, male circumcision, clinical linkage and ART chemoprophylaxis during pregnancy. Viral phylogenetics is used to estimate the proportion of incident infections originating in test villages, and thus the relative contribution of TasP for preventing transmissions. Analysis of results through modeling includes estimating cost effectiveness and estimations of contributions for different prevention interventions.
Description
Other Available Sources
Keywords
Abstracts—September 10, 2013 (Day 3)
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service